ARCHIVES

Study Finds Up To 12 Percent Of Specimens Misdiagnosed

This article is from The Cancer Letter archive.

Vol. 28 No. 10 | October 28, 2005

Download PDF Visit The Full Archive

Related Articles

Ibrutinib Produces 68% Overall Response Rate in Phase II Trial

January 25, 2013

Also in this 8-page issue: NCI closes its Tobacco Intervention Research Clinic, blaming flat budget, slow accrual.

October 15, 2004

Breast Cancer: Working Group Sets Broad Agenda For Genetic Research

January 10, 1997

In Brief: Little Relation of Cancer Incidence To Known Carcinogens Except For Cigarettes, Holleb Says

July 14, 1978

NCI Cooperative Group, Cancer Center Trials Listed

March 27, 2009

Cooper, Frederickson Formally Named To Top Health, NIH Positions

April 25, 1975